Abstract:Background:The intestine is now known as a key metabolic organ that is involved in the development of metabolic complications in obesity and diabetes.Studies on obese and insulin resistant rodents and humans show that small intestine develops a local insulin resistance state, an altered lipid and lipoprotein metabolism, low-grade inflammation and increased paracellular permeability.Because of the complex microenvironment surrounding intestinal epithelial cells, it is not clear so far whether intestinal dyshomeostasis is primarily induced by exogenous obesity-related factors or is a response to obesity-related endogenous alterations in the host.Objectives: To assess the impact of obesity-related endogenous factors (i.e.hyperglycemia, dyslipidemia, inflammation or endocannabinoid system activation) on intestinal epithelial functions in organoids.Methods: Organoids, derived from male C57BL/ 6 mouse duodenum, were incubated 24h with the following conditions: a) inflammatory state (20 mM LPS, 100 nM TNF a, IL-1b and IFNg); b) dyslipidemia (5 mM vs. 2 mM of Palmitate:Oleate [2:1] in 1 mM BSA); c) hyperglycemia (2600 mg/L vs. 1000 mg/L); and d) endocannabinoid system activators(ACEA and Noladin).Results: Incubation of organoids with insulin (30 min, EC50=10 nM) induced a dose-response activation of Akt Ser473 phosphorylation.Insulin signaling was blunted by the induction of an inflammatory state (-50%, p<0.05) and by free fatty acid levels similar to dyslipidemia (-37%, p<0.05) while hyperglycemia only reduce insulin sensitivity at much higher glucose levels than observed in diseases [>4500 mg/L].These obesity-related endogenous factors also impact the expression of several genes related to the epithelial cell functions in the intestine.The inflammatory state increase expression of genes related to intestinal paracellular permeability ( Tjp, Ocln, Marveld2), immune and inflammatory response (Def20, Muc1, Lyz2, Tnf), lipid and lipoprotein metabolism (Mttp, Dgat1/2, Acss2, Acaca) and nutrient transport (Slc2a2/5, Slc5a1, Abcg5/8, Fabp2).Endocannabinoid system activation also led to several changes in the expression of genes related to intestinal paracellular permeability ( Tjp, Marveld2), immune and inflammatory response (Def20, Lyz2, Muc2, Tnf), lipid and lipoprotein metabolism (Mttp, Dgat1, Fabp2) and glucose homeostasis (Gip, Slc2a2/5, Slc5a1) but with divergent effects according to the ligands (ACEA vs. Noladin).Conclusion: This study demonstrates that basolateral exposure of small intestine epithelium organoids to obesity-related factors impact the ability of the cell to signal insulin and suggest the development of alterations in other key intestinal functions.Overall, this study suggests that the host metabolic states may represent an important mechanism in the development of small intestine alteration in obesity.

Diet-induced alteration of intestinal stem cell function underlies obesity and prediabetes in mice

Heterogeneous Development of Β-Cell Populations in Diabetes-Resistant and Susceptible Mice

Abstract 1247: PPARsing epigenetic memory in intestinal stem cells: High-fat diet and oncogenic susceptibility

Lepr+ Mesenchymal Cells Sense Diet to Modulate Intestinal Stem/progenitor Cells Via Leptin–Igf1 Axis

Obesity Modulates Intestinal Intraepithelial T Cell Persistence, CD103 and CCR9 Expression, and Outcome in Dextran Sulfate Sodium-Induced Colitis

SCFAs switch stem cell fate through HDAC inhibition to improve barrier integrity in 3D intestinal organoids from patients with obesity

Gut-associated IgA+ immune cells regulate obesity-related insulin resistance

Nutrient-sensing alteration leads to age-associated distortion of intestinal stem cell differentiating direction

Tu1206 EFFECT OF BACILLUS SUBTILIS AND ENTEROCOCCUS FAECALIS SUPERNATANT ON SERT EXPRESSION IN ENTEROCYTES AND RAT INTESTINAL TISSUES

An Association between Decreased Small Intestinal RNA Modification and Disturbed Glucagon-like Peptide-1 Secretion under High-Fat Diet Stress

Ketone Body Signaling Mediates Intestinal Stem Cell Homeostasis and Adaptation to Diet

Loss of Paneth cells dysregulates gut ILC subsets and enhances weight gain response to high fat diet in a mouse model

Fat and not sugar as the determining factor for gut microbiota changes, obesity, and related metabolic disorders in mice

Dietary Nutrition Regulates Intestinal Stem Cell Homeostasis

Characterization of obesity-related diseases and inflammation using single cell immunophenotyping in two different diet-induced obesity models

Gut Dysbiosis and Adaptive Immune Response in Diet-induced Obesity vs. Systemic Inflammation

EXCESS DIETARY SUGAR ALTERS COLONOCYTE METABOLISM AND IMPAIRS THE EARLY PROLIFERATIVE RESPONSE TO DAMAGE

Abstract 21182: Single-Cell Sequencing Analysis Reveals Impaired Adipose Tissue Stem Cell Program in Obesity

Intestinal Stem Cell-Derived Enteroids from Morbidly Obese Patients Preserve Obesity-Related Phenotypes: Elevated Glucose Absorption and Gluconeogenesis.

Delayed Gut Colonization Changes Future Insulin Resistance and Hepatic Gene Expression but Not Adiposity in Obese Mice

Adipose Tissue Inflammation Is Directly Linked to Obesity-Induced Insulin Resistance, while Gut Dysbiosis and Mitochondrial Dysfunction Are Not Required